1. Home
  2. QUIK vs KALA Comparison

QUIK vs KALA Comparison

Compare QUIK & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$18.39

Market Cap

211.8M

Sector

Technology

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$2.71

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
KALA
Founded
1988
2009
Country
United States
United States
Employees
51
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.8M
172.0M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
QUIK
KALA
Price
$18.39
$2.71
Analyst Decision
Buy
Buy
Analyst Count
1
3
Target Price
$11.00
$31.50
AVG Volume (30 Days)
716.1K
2.9M
Earning Date
05-12-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
67.39
EPS
N/A
N/A
Revenue
$20,112,000.00
N/A
Revenue This Year
$75.17
N/A
Revenue Next Year
$16.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$0.07
52 Week High
$22.69
$20.58

Technical Indicators

Market Signals
Indicator
QUIK
KALA
Relative Strength Index (RSI) 57.95 71.54
Support Level $5.83 $0.32
Resistance Level N/A $3.96
Average True Range (ATR) 2.06 0.23
MACD -0.01 0.29
Stochastic Oscillator 53.05 68.19

Price Performance

Historical Comparison
QUIK
KALA

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: